Development of an orally bioavailable selective inhibitor of the menin-MLL

Genes Dis. 2022 Oct 18;10(5):1735-1738. doi: 10.1016/j.gendis.2022.10.005. eCollection 2023 Sep.

Hai-Jing Zhong^{1

2

3}, Wanhe Wang⁴, Wei Zhou², Jia-Xin Liang¹, Yung-Chi Cheng², Dik-Lung Ma⁴, Chung-Hang Leung^{1

5}

¹ State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
² Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
³ International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou, Guangdong 510632, China.
⁴ Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.
⁵ Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macao SAR, China.

No abstract available